Administration, Metronomic
"Administration, Metronomic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of low doses of a drug or a drug combination over prolonged periods of time usually at a regular interval.
| Descriptor ID |
D059250
|
| MeSH Number(s) |
E02.319.283.199
|
| Concept/Terms |
Administration, Metronomic- Administration, Metronomic
- Administrations, Metronomic
- Metronomic Administration
- Metronomic Administrations
- Metronomic Drug Therapy
- Drug Therapies, Metronomic
- Drug Therapy, Metronomic
- Metronomic Drug Therapies
- Metronomic Drug Administration
- Drug Administration, Metronomic
- Drug Administrations, Metronomic
- Metronomic Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Metronomic".
Below are MeSH descriptors whose meaning is more specific than "Administration, Metronomic".
This graph shows the total number of publications written about "Administration, Metronomic" by people in this website by year, and whether "Administration, Metronomic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Metronomic" by people in Profiles.
-
Editorial - Metronomic chemotherapy. Cancer Lett. 2017 08 01; 400:203.
-
Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer. Mol Cancer Ther. 2015 Dec; 14(12):2677-86.
-
Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer. Mol Cancer Ther. 2014 Jul; 13(7):1750-7.
-
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. Int J Cancer. 2012 Jul 01; 131(1):8-17.
-
A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma. Urol Oncol. 2013 Feb; 31(2):234-40.